Ranitidine
Product Images NDC 10544-056

2 FDA label images from Blenheim Pharmacal, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ranitidine (NDC 10544-056). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Blenheim Pharmacal, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

150mg 20ct (Label Ranitidine Tabss 150mg Bpi(10544 056 20) Amneal(53746 253 05) Rev0)

150mg 20ct (Label Ranitidine Tabss 150mg Bpi(10544 056 20) Amneal(53746 253 05) Rev0)
Ranitidine Tablets USP 150mg packaged by Blenheim Pharmacal, Inc., containing 20 tablets per package. The label includes NDC 10544-056-20 and MFG number 53746-253-05. It states Rx Only and provides storage instructions to keep at controlled room temperature, in a tight, light-resistant container, away from children. The label also notes the active ingredient as Ranitidine Hydrochloride 150mg and the manufacturing by Amed Pharmaceuticals of NY.*
FDA Label Image

Structure (Ranitidine Tablets Usp 1)

Structure (Ranitidine Tablets Usp 1)
Chemical structure of ranitidine, showing its molecular configuration including functional groups such as a nitroethene and a furan ring, as well as an associated hydrochloride (HCl) molecule.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.